Causal relationship of body mass index with autoimmune liver diseases mediated by circulating cytokines: A Mendelian randomization study

循环细胞因子介导的体重指数与自身免疫性肝病之间的因果关系:一项孟德尔随机化研究

阅读:1

Abstract

Observational studies suggest associations between elevated body mass index (BMI) and autoimmune liver diseases (AILDs), yet causal evidence remains limited. This Mendelian randomization (MR) study aimed to elucidate the causal role of BMI in AILDs and identify mediating pathways involving 91 circulating cytokines. Utilizing public genome-wide association study data, univariate and multivariate MR analyses were conducted to assess causal relationships between BMI and 3 AILDs. Mediation MR evaluated cytokine-mediated effects. Inverse variance weighted method served as the primary method, complemented by sensitivity analyses to address pleiotropy and heterogeneity. Genetically predicted higher BMI increased risks of autoimmune hepatitis (AIH; odds ratio [OR] = 1.43, 95% confidence interval [CI] = 1.07-1.93, P = .017) and primary biliary cholangitis (OR = 1.38, 95% CI = 1.14-1.67, P = .001), but inversely correlated with primary sclerosing cholangitis (PSC) risk (OR = 0.78, 95% CI = 0.62-0.98, P = .027). Multivariate MR confirmed BMI's independent effects after adjusting for alcohol and tobacco use. Mediation analysis indicated that tumor necrosis factor receptor superfamily (TNFRSF) member 9 could mediate the positive effects of higher BMI on AIH (OR = 1.02, 95% CI = 1.0005-1.07, 8.2%). Delta/Notch-like epidermal growth factor-related receptor (OR = 0.93, 95% CI = 0.87-0.98, 1.7%), interleukin [IL-8] (OR = 0.97, 95% CI = 0.92-0.99, 14.2%), and TNFRSF12 (OR = 0.95, 95% CI = 0.90-0.99, 18.7%) levels could mediate the negative effects of higher BMI on PSC. This study provided genetic evidence that higher BMI could increase the risk of AIH and primary biliary cholangitis and reduce the risk of PSC. Key circulating cytokines, such as TNFRSF 9, Delta/Notch-like epidermal growth factor-related receptor, TNFRSF12, and interleukin-8, could mediate the pathogenic pathways from BMI to AILDs. These findings highlight potential therapeutic targets and underscore the need for tailored prevention strategies in high-BMI populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。